Juvenile Diabetes Research Foundation Canada

235 Yorkland Blvd. Suite 600
Toronto, ON M2J 4Y8
President & CEO: Dave Prowten
Board Chair: Lorne Shiff

Charitable Reg. #:11897 6604 RR0001


Ci's Star Rating is calculated based on the following independent metrics:

Unlock Charity Ratings



Audited financial statements for current and previous years available on the charity’s website.



Grade based on the charity's public reporting of the work it does and the results it achieves.



The demonstrated impact per dollar Ci calculates from available program information.


Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.



For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 41 cents are available for programs.

My anchor


About Juvenile Diabetes Research Foundation Canada:

Founded in 1974 by parents of children with diabetes, Juvenile Diabetes Research Foundation Canada (JDRF) is the largest funder and advocate for Type 1 diabetes (T1D) research in Canada. Its focus is to find a cure for T1D and its complications. Type 1 diabetes is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone people need to get energy from food.  JDRF reports that 300,000 Canadians live with T1D, and the incidence rate is rising by 5.1% per year. On average, T1D management requires 1,460 insulin shots per year. T1D often leads to life-threatening and debilitating complications which may include kidney failure, blindness, heart disease, stroke, nerve damage and amputation. The frequency of T1D among children under the age of 14 is rising, with rates doubling over the last 20 years in children under 5 years old.  

JDRF funds research focused on three main ideas: cure, prevention and treatment. In F2017, research focused on artificial pancreases to deliver insulin (9%), beta cell replacement to deliver insulin (16%), complications of diabetes (7%), prevention (21%), glucose control (9%), and restoration of the body’s immune system (35%). In F2017, Juvenile Diabetes Research Foundation Canada funded 516 international grants, including 140 new research grants and 38 Canadian research projects. The grants also funded 70 active clinical trials globally for potential T1D therapies.  

In F2017, JDRF actively ran 3 main advocacy activities. Manitoba Lobby Day advocates for insulin pump coverage for adults over 17 years old. Advocating for Kids aims to shape policies about care for kids with T1D at schools. Rallying for the Disability Tax Credit advocates for the reinstation of the disability tax credit of about $15,000/year to individuals living with T1D. 

This is the most recent output data available at the time of profile update 

My anchor

Results and Impact

The 2017 JDRF annual report highlights a JDRF-funded research project called CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trail. The study shows that monitoring a woman’s blood sugar levels using a continuous glucose monitor (CGM) during pregnancy leads to better outcomes. Specifically, expectant mothers who used a CGM spent an extra 100 minutes each day with blood sugar levels in the recommended range in late pregnancy. For every six women using a real-time CGM device, there was one fewer baby experiencing a hypoglycemic (low blood sugar) event. And for every eight women using the device, there was one less neonatal intensive care unit admission over 24 hours.  

Thanks to JDRF’s advocacy efforts, in October 2017 Ontario’s Ministry of Education issued a new draft Policy Program Memorandum that required all school boards in the province to have board-level policies aimed at keeping students with diabetes (and other medical conditions) safer at school. In addition, in December 2017, the Government of Canada and CRA announced they would rescind the interpretation, making it possible for adults with T1D to qualify for the Disability Tax Credit again. 

My anchor


Juvenile Diabetes Research Foundation Canada is a Major 100 charity with donations of $22.4m in F2017. Administrative costs were 21% of revenues (excluding investment income), and fundraising costs were 39% of donations. For every dollar donated, 41 cents go to the cause, which is outside of Charity Intelligence’s range for reasonable overhead spending. 

The Foundation has funding reserves of $7.0m, of which $86k is donor-endowed. Excluding donor-endowed funds, the Foundation has enough funds on hand to cover just over 10 months of grants and programs. 

This charity report is an update that has been sent to Juvenile Diabetes Research Foundation Canada for review. Changes and edits may be forthcoming. 

Updated on August 13, 2019 by Caroline McKenna. 

Financial Review

Financial Ratios

Fiscal year ending December
Administrative costs as % of revenues 20.5%21.5%20.9%
Fundraising costs as % of donations 38.6%47.0%48.9%
Total overhead spending 59.1%68.4%69.8%
Program cost coverage (%) 84.9%92.8%93.8%

Summary Financial Statements

All figures in $000s
Donations 22,42320,02019,963
Government funding 429942
Lotteries (net) 00272
Investment income 00128
Total revenues 22,46520,11920,405
Program costs 1,3871,3051,118
Grants 6,7296,4827,862
Administrative costs 4,6084,3154,233
Fundraising costs 8,6639,4079,757
Total spending 21,38721,50922,970
Cash flow from operations 1,078(1,390)(2,565)
Capital spending 1,1601039
Funding reserves 6,9707,3078,501

Note: Ci used government funding amounts recorded in the charity’s T3010 filing with the CRA, which was backed out of donations. Amortization was backed out of administrative costs and included separately as a non-cash expense.   

Salary Information

Full-time staff: 110

Avg. Compensation: $67,019

Top 10 staff salary range:

$350k +
$300k - $350k
$250k - $300k
$200k - $250k
$160k - $200k
$120k - $160k
$80k - $120k
$40k - $80k
< $40k

Information from most recent CRA Charities Directorate filings for F2017

My anchor

Comments & Contact

Comments added by the Charity:

These comments refer to an outdated Charity Intelligence profile:

JDRF directs funds to deliver both near-term benefits for people who live with type 1 diabetes and, ultimately, a cure. Our research focus is on two distinct and related aims of science leading to a cure and science leading to better treatments. JDRF also provides outreach support services, volunteer and advocacy opportunities.

Canada’s excellence in diabetes research and breakthroughs continues in the creation of the JDRF Canadian Clinical Trial Network. Launched in 2010 through a partnership with the Government of Canada, JDRF CCTN began as a $33.9M investment to accelerate the testing of new technologies and treatments for Canadians living with type 1 diabetes and its complications.

JDRF is positively impacting the lives and futures of people living with diabetes. Thanks to the support of our generous donors, JDRF has made significant advancements and progress toward positive health outcomes for people living with type 1 diabetes. For example:

  • JDRF-funded research with industry partners on immune therapies is progressing to the most advanced stages of clinical testing
  • JDRF now funds over 50 human clinical trials, as opposed to five in 2003.
  • JDRF is perfecting insulin treatments, a critical component of JDRF’s Artificial Pancreas Project and impact on the daily lives of those living with type 1 diabetes.
  • Recent advances in diabetic eye disease, funded in part by JDRF, hold the potential to help prevent and reverse eye disease in people with type 1 diabetes.

We remain committed to a cure while investing in better treatments for today.

Charity Contact

Website: www.jdrf.ca
This email address is being protected from spambots. You need JavaScript enabled to view it.